A comparison of the patient-borne costs of therapy with gamma globulin given at the hospital or at home.
The major aim of this study was to estimate and compare the patient-borne costs of lifelong subcutaneous gamma globulin therapy at the hospital and at home. Thirty patients were included and the data were collected with a questionnaire. The introduction of self-therapy at home reduced the total yearly costs by approximately 50% and the out-of-pocket expenses for the patients by 85%.
Gardulf
A
A
Huddinge University Hospital.
Möller
G
G
Jonsson
E
E
D000293:Adolescent; D000328:Adult; D000368:Aged; D017074:Common Variable Immunodeficiency / Q000191:economics / Q000628:therapy; D003365:Costs and Cost Analysis; D005260:Female; D018718:Home Infusion Therapy / Q000191:economics* / Q000295:instrumentation / Q000706:statistics & numerical data; D006760:Hospitalization / Q000191:economics* / Q000706:statistics & numerical data; D006801:Humans; D007279:Injections, Subcutaneous / Q000191:economics / Q000295:instrumentation; D008297:Male; D008875:Middle Aged; D012648:Self Care / Q000191:economics* / Q000295:instrumentation / Q000706:statistics & numerical data; D013548:Sweden; D013997:Time Factors; D005719:gamma-Globulins / Q000008:administration & dosage / Q000191:economics*
D005719:gamma-Globulins